Background: A positive calcium balance may contribute to vascular calcification, while a negative balance increases iPTH. We explored the impact of different dialysate calcium concentrations on bone and mineral metabolism parameters according to pre-dialysis serum calcium levels. Results: Fifty-six hemodialysis patients were dialyzed with 3.0 or 2.5 mEq/l dialysate [calcium] in a crossover study of two weeks. Bone mineral metabolites were measured prior to and following the hemodialysis session. A 3.0 mEq/l dialysate [calcium] increased more post-dialysis total calcium and ionized calcium than 2.5 mEq/l dialysate [calcium]. The mildest dialysis-induced changes in calcium and PTH were observed in patients with pre-dialysis serum calcium <8.75 mg/dl dialyzed with 2.5 mEq/l dialysate [calcium] and in patients with pre-dialysis serum calcium >9.15 mg/dl dialyzed with 3.0 mEq/l calcium dialysate. Conclusion: In conclusion, the individualization of dialysate calcium concentration according to baseline pre-dialysis serum calcium may prevent major excursions in post-dialysis serum calcium and iPTH levels. Short Summary: High calcium dialysate may increase serum calcium in hemodialysis patients, while low dialysate calcium may increase PTH. Individualization of dialysate calcium according to predialysis serum calcium levels may prevent or decrease unwanted excursions of both serum calcium and PTH.

Keywords:
Calcium dialysate, Individualization, Parathormone, Serum calcium, Vascular calcifications
1.
Abdelmalek JA, Stark P, Walther CP, Ix JH, Rifkin DE: Associations between coronary calcification on chest radiographs and mortality in hemodialysis patients. Am J Kidney Dis 2012;60:990-997.
2.
Ohya M, Otani H, Kimura K, Saika Y, Fujii R, Yukawa S, Shigematsu T: Vascular calcification estimated by aortic calcification area index is a significant predictive parameter of cardiovascular mortality in hemodialysis patients. Clin Exp Nephrol 2011;15:877-883.
3.
Noordzij M, Cranenburg EM, Engelsman LF, Hermans MM, Boeschoten EW, Brandenburg VM, Bos WJ, Kooman JP, Dekker FW, Ketteler M, Schurgers LJ, Krediet RT, Korevaar JC; NECOSAD Study Group: Progression of aortic calcification is associated with disorders of mineral metabolism and mortality in chronic dialysis patients. Nephrol Dial Transplant 2011;26:1662-1669.
4.
IOM (Institute of Medicine): Dietary Reference Intakes for Calcium and Vitamin D. Washington, DC, National Academies Press, 2011.
5.
Spiegel DM, Brady K: Calcium balance in normal individuals and in patients with chronic kidney disease on low- and high-calcium diets. Kidney Int 2012;81:1116-1122.
6.
Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group: KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl 2009;113:S1-S130.
7.
London GM, Marchais SJ, Guérin AP, Boutouyrie P, Métivier F, de Vernejoul MC: Association of bone activity, calcium load, aortic stiffness, and calcifications in ESRD. J Am Soc Nephrol 2008;19:1827-1835.
8.
Barreto FC, Barreto DV, Moysés RM, Neves KR, Canziani ME, Draibe SA, Jorgetti V, Carvalho AB: K/DOQI-recommended intact PTH levels do not prevent low-turnover bone disease in hemodialysis patients. Kidney Int 2008;73:771-777.
9.
Morton AR, Garland JS, Holden RM: Is the calcium correct? Measuring serum calcium in dialysis patients. Semin Dial 2010;23:283-289.
10.
Bushinsky DA: Contribution of intestine, bone, kidney, and dialysis to extracellular fluid calcium content. Clin J Am Soc Nephrol 2010;5(suppl 1):S12-S22.
11.
Gotch FA, Kotanko P, Thijssen S, Levin NW: The KDIGO guideline for dialysate calcium will result in an increased incidence of calcium accumulation in hemodialysis patients. Kidney Int 2010;78:343-350.
12.
Gotch F, Levin NW, Kotanko P: Calcium balance in dialysis is best managed by adjusting dialysate calcium guided by kinetic modeling of the interrelationship between calcium intake, dose of vitamin D analogues and the dialysate calcium concentration. Blood Purif 2010;29:163-176.
13.
National Kidney Foundation: K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 2003;42(suppl 3):S1-S201.
14.
Torregrosa JV, Bover J, Cannata Andía J, Lorenzo V, de Francisco AL, Martínez I, Rodríguez Portillo M, Arenas L, González Parra E, Caravaca F, Martín-Malo A, Fernández Giráldez E, Torres A; Spanish Nephrology Society: Spanish Society of Nephrology recommendations for controlling mineral and bone disorder in chronic kidney disease patients (S.E.N.-M.B.D.). Nefrologia 2011;31(suppl 1):3-32.
15.
Pun PH, Horton JR, Middleton JP: Dialysate calcium concentration and the risk of sudden cardiac arrest in hemodialysis patients. Clin J Am Soc Nephrol 2013;8:797-803.
16.
Basile C, Libutti P, Di Turo AL, et al: Effect of dialysate calcium concentrations on parathyroid hormone and calcium balance during a single dialysis session using bicarbonate hemodialysis: a crossover clinical trial. Am J Kidney Dis 2012;59:92-101.
17.
Bosticardo G, Malberti F, Basile C, et al: Optimizing the dialysate calcium concentration in bicarbonate haemodialysis. Nephrol Dial Transplant 2012;27:2489-2496.
18.
Brandenburg VM, Ketteler M, Rodriguez M: Ten years of progress in our understanding of uremic vascular calcification and disease: a decade summarized in 20 steps. Kidney Int Suppl 2011;1:116-121.
19.
Goodman WG, Goldin J, Kuizon BD, et al: Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 2000;342:1478-1483.
20.
Blacher J, Guerin AP, Pannier B, et al: Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension 2001;38:938-942.
21.
Block GA, Klassen PS, Lazarus JM, et al: Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 2004;15:2208-2218.
22.
Shroff RC, McNair R, Skepper JN, et al: Chronic mineral dysregulation promotes vascular smooth muscle cell adaptation and extracellular matrix calcification. J Am Soc Nephrol 2010;21:103-112.
23.
Roman-Garcia P, Carrillo-Lopez N, Fernandez-Martin JL, et al: High phosphorus diet induces vascular calcification, a related decrease in bone mass and changes in the aortic gene expression. Bone 2010;46:121-128.
24.
Yang H, Curinga G, Giachelli CM: Elevated extracellular calcium levels induce smooth muscle cell matrix mineralization in vitro. Kidney Int 2004;66:2293-2299.
25.
LeBoeuf A, Mac-Way F, Utescu MS, et al: Impact of dialysate calcium concentration on the progression of aortic stiffness in patients on haemodialysis. Nephrol Dial Transplant 2011;26:3695-3701.
26.
Kim JK, Moon SJ, Park HC, et al: Effects of lowering dialysate calcium concentrations on arterial stiffness in patients undergoing hemodialysis. Korean J Intern Med 2011;26:320-327.
27.
Raimann JG, Thijssen S, Levin NW: A brief review of external mass balance and internal calcium redistribution in dialysis patients - is calcium a uremic toxin? J Ren Nutr 2012;22:186-190.
28.
Malberti F, Ravani P: The choice of the dialysate calcium concentration in the management of patients on haemodialysis and haemodiafiltration. Nephrol Dial Transplant 2003;18(suppl 7):vii37-vii40.
29.
Bushinsky DA: Clinical application of calcium modeling in patients with chronic kidney disease. Nephrol Dial Transplant 2012;27:10-13.
30.
Mendoza FJ, Lopez I, Montes de Oca A, Perez J, Rodriguez M, Aguilera-Tejero E: Metabolic acidosis inhibits soft tissue calcification in uremic rats. Kidney Int 2008;73:407-414.
31.
de Solis AJ, González-Pacheco FR, Deudero JJ, Neria F, Albalate M, Petkov V, Susanibar L, Fernandez-Sanchez R, Calabia O, Ortiz A, Caramelo C: Alkalinization potentiates vascular calcium deposition in an uremic milieu. J Nephrol 2009;22:647-653.
32.
Lomashvili K, Garg P, O'Neill WC: Chemical and hormonal determinants of vascular calcification in vitro. Kidney Int 2006;69:1464-1470.
33.
Finer G, Price HE, Shore RM, White KE, Langman CB: Hyperphosphatemic familial tumoral calcinosis: response to acetazolamide and postulated mechanisms. Am J Med Genet A 2014;164A:1545-1549.
© 2014 S. Karger AG, Basel
2014
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.